Cell Cycle–Mediated Regulation of Secondary Ig Diversification
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2100880 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Amanda Bello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Institute of Biochemistry and Biophysics, Faculty of Biological Sciences, Friedrich Schiller University, Jena, Germany. Hauptthemen laut MEDLINE: Genes, Immunoglobulin, Immunoglobulin Class Switching. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe.
Abstract (Originalsprache)
Secondary Ig diversification in B cells requires the deliberate introduction of DNA damage into the Ig genes by the enzyme activation-induced cytidine deaminase (AID) and the error-prone resolution of AID-induced lesions. These processes must be tightly regulated because they may lead to lymphomagenesis if they act on genes other than the Ig genes. Since B cells may limit secondary Ig diversification mechanisms during the cell cycle to minimize genomic instability, we restricted the activity of AID specifically to the G1 or S/G2 phase to investigate the cell cycle contribution to the regulation of somatic hypermutation, class switch recombination, and Ig gene conversion in human, murine, and avian B cells, respectively. The efficient induction of AID in different cell cycle phases allowed us for the first time, to our knowledge, to discriminate G1- from S/G2-specific events of regulation. We show that the processes of Ig gene conversion and C/G mutagenesis during somatic hypermutation can be achieved throughout the cell cycle, whereas A/T mutagenesis and class switch recombination require AID-mediated deamination in G1. Thus, AID activity in G1, but not in S/G2, leads to the efficient accomplishment of all mechanisms of secondary Ig diversification. Our findings refine the current state-of-the-art knowledge in the context of the regulation of secondary Ig diversification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Institute of Biochemistry and Biophysics, Faculty of Biological Sciences, Friedrich Schiller University, Jena, Germany.
ORCID-Profile: Antonia Müller, Liane N Giebeler
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
Zitieren
APA
Bello, A., Müller, A., Hirth, G., Giebeler, L. N., Böttcher, K., Voigt, S., & Jungnickel, B. (2023). Cell Cycle–Mediated Regulation of Secondary Ig Diversification. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2100880
Vancouver
Bello A, Müller A, Hirth G, Giebeler LN, Böttcher K, Voigt S, et al. Cell Cycle–Mediated Regulation of Secondary Ig Diversification. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2100880
BibTeX
@article{Bello2023,
author = {Bello, Amanda and Müller, Antonia and Hirth, Gianna and Giebeler, Liane N and Böttcher, Katrin and Voigt, Stefanie and Jungnickel, Berit},
title = {Cell Cycle–Mediated Regulation of Secondary Ig Diversification},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2100880}
}
EUVIMED